This update is therefore to let all of you in the community know that we are still here and continuing to work hard in our bid to help the many millions of people living with Long Covid.

Once the results have been fully analysed and then checked by other independent researchers (a process called peer review) we will let you know the outcome. This process takes a long time.

Next steps will be to analyse the data to see how feasible it is for people with Long Covid to receive this drug and look for any suggestions as to how the drug has affected participants.

Access has been a “postcode lottery”, says @profmarkfaghy.bsky.social, an associate professor in respiratory physiology at @derbyuni.bsky.social
and policy advisor for @longcovidkids.bsky.social
He adds that children and young people are at a “disadvantage from the outset”.

More than happy to chat @jonathandaviesmp.bsky.social 🙏🏼